{"transactions":[{"id":2441677,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":131569,"kind":"person","name":"Smolinski Stephen","position":1,"cik":"0001721031","reported_name":"Smolinski Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-06T16:19:56.000Z","date":"2022-01-04","kind":"grant","acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest over four years, with the first 25% vesting on the first anniversary of the grant date, and the remainder vesting in equal monthly installments over the following 36 months, subject to the reporting person's continued service on each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":1.7,"expiration_date":"2032-01-04","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001062993-22-000731","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721031/000106299322000731/form4.xml","form_type":"4"}},{"id":3318668,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":131569,"kind":"person","name":"Smolinski Stephen","position":1,"cik":"0001721031","reported_name":"Smolinski Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-01-06T20:08:56.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to 25% on January 2, 2021. The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":2.3,"expiration_date":"2030-01-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001453687-20-000015","document":"wf-form4_157835931999296.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721031/000145368720000015/wf-form4_157835931999296.xml","form_type":"4"}},{"id":3395409,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":131569,"kind":"person","name":"Smolinski Stephen","position":1,"cik":"0001721031","reported_name":"Smolinski Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-10-09T16:20:42.000Z","date":"2019-10-07","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest as to 50% of the shares on October 7, 2020, and the remaining 50% of the shares on October 7, 2021."}],"balance_after":180000,"derivative":{"exercise_price":1.75,"expiration_date":"2029-10-06","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0001453687-19-000148","document":"wf-form4_157065241992844.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721031/000145368719000148/wf-form4_157065241992844.xml","form_type":"4"}},{"id":3433301,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":131569,"kind":"person","name":"Smolinski Stephen","position":1,"cik":"0001721031","reported_name":"Smolinski Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2019-08-20T16:32:51.000Z","date":"2019-08-20","kind":"grant","acquired":true,"shares":13812,"price":1.81,"value":24999.72,"ownership":{"direct":true},"balance_after":13812,"source":{"system":"sec-edgar","filing":"0001453687-19-000125","document":"wf-form4_156633315653823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721031/000145368719000125/wf-form4_156633315653823.xml","form_type":"4"}},{"id":3700466,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":131569,"kind":"person","name":"Smolinski Stephen","position":1,"cik":"0001721031","reported_name":"Smolinski Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-01-08T16:21:18.000Z","date":"2019-01-07","kind":"grant","acquired":true,"shares":100000,"price":2.6,"value":260000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest as to 25% on January 7, 2020.  The remainder of the underlying shares will vest in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":2.6,"expiration_date":"2029-01-06","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001453687-19-000013","document":"wf-form4_154698246209632.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721031/000145368719000013/wf-form4_154698246209632.xml","form_type":"4"}},{"id":3889037,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":131569,"kind":"person","name":"Smolinski Stephen","position":1,"cik":"0001721031","reported_name":"Smolinski Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-19T19:05:58.000Z","date":"2018-06-15","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares on June 15, 2019.  The remainder of the shares will vest in 36 equal monthly installments thereafter."}],"balance_after":80000,"derivative":{"exercise_price":12.75,"expiration_date":"2028-06-14","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001638599-18-000678","document":"doc4_5479.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721031/000163859918000678/doc4_5479.xml","form_type":"4"}},{"id":4156615,"issuer":{"id":6015,"kind":"organization","name":"Cartesian Therapeutics, Inc."},"owners":[{"id":131569,"kind":"person","name":"Smolinski Stephen","position":1,"cik":"0001721031","reported_name":"Smolinski Stephen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-11-20T16:09:58.000Z","date":"2017-11-17","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests as to 25% of the shares on October 26, 2018. The remainder of the shares will vest in 36 equal monthly installments thereafter."}],"balance_after":80000,"derivative":{"exercise_price":10.23,"expiration_date":"2027-11-16","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001638599-17-001155","document":"doc4_5082.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1721031/000163859917001155/doc4_5082.xml","form_type":"4"}}]}